Long-term, open-label treatment with triple olmesartan (O)/amlodipine (A)/hydrochlorothiazide (H) combination therapy in moderate-to-severe hypertension patients (pts)

被引：0
|
作者：
Volpe, M. [1 ]
Ammentorp, B. [2 ]
Laeis, P. [3 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
[2] IRCCS Neuromed, Pozzilli, Italy
[3] Daiichi Sankyo Europe GmbH, Munich, Germany
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 775
页数：1
相关论文
共 50 条
  • [1] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Massimo Volpe
    Alejandro de la Sierra
    Bettina Ammentorp
    Petra Laeis
    Advances in Therapy, 2014, 31 : 561 - 574
  • [2] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Volpe, Massimo
    de la Sierra, Alejandro
    Ammentorp, Bettina
    Laeis, Petra
    ADVANCES IN THERAPY, 2014, 31 (05) : 561 - 574
  • [3] Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension An Open-Label, Long-Term Study
    Volpe, Massimo
    Miele, Cristina
    Haag, Uwe
    CLINICAL DRUG INVESTIGATION, 2009, 29 (06) : 381 - 391
  • [4] Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension
    L C Rump
    E Ambrosioni
    M Burnier
    W Hörl
    A J Rabelink
    Journal of Human Hypertension, 2006, 20 : 299 - 301
  • [5] Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension
    Rump, LC
    Ambrosioni, E
    Burnier, M
    Hörl, W
    Rabelink, AJ
    JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (04) : 299 - 301
  • [6] Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe HypertensionAn Open-Label, Long-Term Study
    Massimo Volpe
    Cristina Miele
    Uwe Haag
    Clinical Drug Investigation, 2009, 29 : 381 - 391
  • [7] Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study
    Murray, Alexander V.
    Koenig, Wolfgang
    Garcia-Puig, Juan
    Patel, Samir
    Uddin, Alkaz
    Zhang, Jack
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (12): : 821 - 827
  • [8] Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
    Kereiakes, Dean J.
    Chrysant, Steven G.
    Izzo, Joseph L.
    Littlejohn, Thomas, III
    Oparil, Suzanne
    Melino, Michael
    Lee, James
    Fernandez, Victor
    Heyrman, Reinilde
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (03): : 149 - 157
  • [9] A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension
    Rakugi, Hiromi
    Shimizu, Kohei
    Nishiyama, Yuya
    Sano, Yuhei
    Umeda, Yuusuke
    BLOOD PRESSURE, 2018, 27 (03) : 125 - 133
  • [10] Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China
    Gao, Pingjin
    Mei, Kezhi
    Li, Hongwei
    Dai, Qiuyan
    Guo, Xingui
    Zhang, Daifu
    Jin, Zhimin
    You, Hua
    Ding, Hong
    Lu, Ke
    Zhou, Shuxian
    Peng, Xiaoling
    Xu, Hui
    Yin, Pengfei
    Yu, Licheng
    Pi, Lin
    Hua, Qi
    Yang, Ming
    Yu, Xiaowei
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2019, 90 : 99 - 105
12345